$CTHR
CHARLES & COLVARD LTD

2023 Q2 Form 10-Q Financial Statement

#000114036123023010 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $5.560M $6.642M $9.752M
YoY Change -40.24% -31.89% 3.35%
Cost Of Revenue $4.680M $4.493M $5.297M
YoY Change -15.46% -15.17% 3.99%
Gross Profit $890.0K $2.149M $4.455M
YoY Change -76.38% -51.77% 2.6%
Gross Profit Margin 16.01% 32.35% 45.69%
Selling, General & Admin $4.340M $4.321M $4.039M
YoY Change 15.81% 6.97% 22.26%
% of Gross Profit 487.64% 201.09% 90.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $170.0K $168.4K $112.0K
YoY Change 31.67% 50.36% -24.56%
% of Gross Profit 19.1% 7.84% 2.51%
Operating Expenses $4.330M $4.321M $4.039M
YoY Change 15.54% 6.97% 22.26%
Operating Profit -$3.440M -$2.172M $415.9K
YoY Change -16962.75% -622.31% -59.96%
Interest Expense $130.0K $69.16K $1.120K
YoY Change 651.01% 6075.0% -53.57%
% of Operating Profit 0.27%
Other Income/Expense, Net $69.16K $1.120K
YoY Change 6074.91% -159.83%
Pretax Income -$9.210M -$2.103M $417.0K
YoY Change -12426.02% -604.32% -59.78%
Income Tax $40.00K $6.290M $78.00K
% Of Pretax Income 18.71%
Net Earnings -$9.250M -$8.396M $338.5K
YoY Change -22788.25% -2580.3% -67.33%
Net Earnings / Revenue -166.37% -126.41% 3.47%
Basic Earnings Per Share -$0.28 $0.01
Diluted Earnings Per Share -$0.30 -$0.28 $0.01
COMMON SHARES
Basic Shares Outstanding 30.52M 30.52M 30.48M
Diluted Shares Outstanding 30.34M 31.27M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.45M $10.91M $16.86M
YoY Change -33.31% -35.27% -14.01%
Cash & Equivalents $10.45M $10.91M $16.86M
Short-Term Investments
Other Short-Term Assets $6.020M $5.940M $6.378M
YoY Change -10.16% -6.87% 449.85%
Inventory $7.476M $7.890M $13.44M
Prepaid Expenses
Receivables $380.1K $933.6K $1.816M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.58M $25.68M $38.50M
YoY Change -31.47% -33.3% 7.55%
LONG-TERM ASSETS
Property, Plant & Equipment $2.492M $2.318M $4.717M
YoY Change 31.05% -50.87% 406.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $49.66K $50.39K $24.98M
YoY Change 0.0% -99.8% 50206.56%
Total Long-Term Assets $24.31M $30.70M $29.94M
YoY Change -27.1% 2.52% 38.59%
TOTAL ASSETS
Total Short-Term Assets $24.58M $25.68M $38.50M
Total Long-Term Assets $24.31M $30.70M $29.94M
Total Assets $48.88M $56.37M $68.44M
YoY Change -29.37% -17.63% 19.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.786M $3.117M $3.131M
YoY Change 8.75% -0.44% 7.19%
Accrued Expenses $1.395M $1.143M $2.054M
YoY Change -9.76% -44.34% 0.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.062M $5.134M $6.035M
YoY Change 3.78% -14.93% -1.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.050M $2.252M $3.051M
YoY Change -27.99% -26.19% -19.51%
Total Long-Term Liabilities $2.048M $2.252M $3.051M
YoY Change -28.07% -26.19% -25.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.062M $5.134M $6.035M
Total Long-Term Liabilities $2.048M $2.252M $3.051M
Total Liabilities $9.110M $7.386M $9.086M
YoY Change -5.61% -18.71% -11.33%
SHAREHOLDERS EQUITY
Retained Earnings -$43.18M -$33.93M
YoY Change 82.96%
Common Stock $83.45M $83.41M
YoY Change 0.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $39.77M $48.99M $59.35M
YoY Change
Total Liabilities & Shareholders Equity $48.88M $56.37M $68.44M
YoY Change -29.37% -17.63% 19.23%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$9.250M -$8.396M $338.5K
YoY Change -22788.25% -2580.3% -67.33%
Depreciation, Depletion And Amortization $170.0K $168.4K $112.0K
YoY Change 31.67% 50.36% -24.56%
Cash From Operating Activities -$50.00K -$773.2K $981.7K
YoY Change -90.57% -178.76% -56.56%
INVESTING ACTIVITIES
Capital Expenditures $350.0K $266.7K $474.6K
YoY Change -228.91% -43.79% 503.59%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$350.0K -$281.5K -$485.7K
YoY Change 28.91% -42.05% 38.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 105.0K
YoY Change -100.0% -100.0% -88.2%
NET CHANGE
Cash From Operating Activities -50.00K -773.2K 981.7K
Cash From Investing Activities -350.0K -281.5K -485.7K
Cash From Financing Activities 0.000 0.000 105.0K
Net Change In Cash -400.0K -1.055M 600.9K
YoY Change -45.38% -275.51% -78.54%
FREE CASH FLOW
Cash From Operating Activities -$50.00K -$773.2K $981.7K
Capital Expenditures $350.0K $266.7K $474.6K
Free Cash Flow -$400.0K -$1.040M $507.1K
YoY Change 54.48% -305.09% -76.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
288548
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5851904
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
388403
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
30287
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-34
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33785281
us-gaap Operating Income Loss
OperatingIncomeLoss
2815797
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
350198
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1250296
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
415868
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111987
CY2023Q1 us-gaap Margin Deposit Assets
MarginDepositAssets
30
CY2022Q2 us-gaap Margin Deposit Assets
MarginDepositAssets
461000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4638761
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
477285
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
884030
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6641799
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2172119
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
168385
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
266747
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9751835
dei Trading Symbol
TradingSymbol
CTHR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001015155
cthr Jewel Inventory Not Mounted In Finished Jewelry Settings
JewelInventoryNotMountedInFinishedJewelrySettings
0.5
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-23329
dei Entity Registrant Name
EntityRegistrantName
Charles & Colvard, Ltd.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-1928817
dei Entity Address Address Line1
EntityAddressAddressLine1
170 Southport Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Morrisville
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27560
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
468-0399
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30523705
dei Security12b Title
Security12bTitle
Common Stock, no par value per share
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
250000
CY2022Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
451815
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34594
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8396008
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
30523705
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
48987290
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
257370
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
198523
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
104999
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
338508
CY2022Q1 us-gaap Shares Outstanding
SharesOutstanding
30688796
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
59350012
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
650917
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1414
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;">Reclassification </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">– </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">Certain </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">amounts in the Company’s condensed consolidated financial statements </span><span style="font-family: 'Times New Roman';">as of June 30, 2022 have been reclassified to conform to current presentation, principally amounts presented in Note 7, “Accrued Expenses and Other Liabilities”, relating to the combination of accrued sales tax and accrued franchise taxes, which had previously been presented separately. These reclassifications had no impact on the Company’s condensed consolidated financial position or condensed consolidated results of operations as of or for the three and nine months ended March 31, 2023 and 2022 and as of June 30, 2022.</span></div>
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
474590
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24382003
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4493125
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5296530
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14650910
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17347026
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6641799
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9751835
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24382003
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33785281
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
376830
CY2022Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
89120
CY2023Q1 cthr Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
33329286
CY2022Q2 cthr Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
33512800
CY2023Q1 us-gaap Inventory Net
InventoryNet
7889917
CY2022Q2 us-gaap Inventory Net
InventoryNet
11024276
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
25439369
CY2022Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
22488524
CY2023Q1 cthr Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
33329286
CY2022Q2 cthr Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
33512800
CY2023Q1 cthr Work In Process Inventories Issued To Active Production Jobs
WorkInProcessInventoriesIssuedToActiveProductionJobs
1410000
CY2022Q2 cthr Work In Process Inventories Issued To Active Production Jobs
WorkInProcessInventoriesIssuedToActiveProductionJobs
2760000
cthr Lessee Operating Lease Minimum Notice Period For Extension Of Lease Term
LesseeOperatingLeaseMinimumNoticePeriodForExtensionOfLeaseTerm
P270D
CY2021Q1 cthr Lessee Operating Lease Rent Abatement
LesseeOperatingLeaseRentAbatement
214000
CY2021Q1 cthr Lessee Operating Lease Allowance For Leasehold Improvements
LesseeOperatingLeaseAllowanceForLeaseholdImprovements
545000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
434132
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
452866
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
275465
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
614443
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
233351
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
341706
CY2023Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
200243
CY2022Q2 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
137467
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1143192
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1546483
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6290000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5860000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
485000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.3106
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.172
CY2023Q1 cthr Lessee Operating Lease Area
LesseeOperatingLeaseArea
36350
CY2023Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q1 cthr Lessee Operating Lease Reimbursement For Leasehold Improvements
LesseeOperatingLeaseReimbursementForLeaseholdImprovements
506000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31268410
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2336334
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
874177
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2251581
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3125758
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
193000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
193000
us-gaap Operating Lease Cost
OperatingLeaseCost
578000
us-gaap Operating Lease Cost
OperatingLeaseCost
596000
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0281
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M29D
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
219393
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
893660
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
918236
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
943487
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
317327
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3292103
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
166345
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3125758
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
874177
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2251581
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
237000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
160000
us-gaap Operating Lease Payments
OperatingLeasePayments
704000
us-gaap Operating Lease Payments
OperatingLeasePayments
330000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30387303
CY2023Q1 us-gaap Other Notes Payable
OtherNotesPayable
0
us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
358116
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
451815
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Dividends Cash
DividendsCash
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34594
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
198523
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
209319
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
676934
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31271677
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8396008
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
338508
us-gaap Net Income Loss
NetIncomeLoss
-10327981
us-gaap Net Income Loss
NetIncomeLoss
2333145
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30344954
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30484897
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30387303
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30286195
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
783513
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
985482
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30344954
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07

Files In Submission

Name View Source Status
cthr-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001140361-23-023010-index-headers.html Edgar Link pending
0001140361-23-023010-index.html Edgar Link pending
0001140361-23-023010.txt Edgar Link pending
0001140361-23-023010-xbrl.zip Edgar Link pending
brhc20052247_10q.htm Edgar Link pending
brhc20052247_exhibit31-1.htm Edgar Link pending
brhc20052247_exhibit31-2.htm Edgar Link pending
brhc20052247_exhibit32-1.htm Edgar Link pending
brhc20052247_exhibit32-2.htm Edgar Link pending
cthr-20230331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
cthr-20230331_def.xml Edgar Link unprocessable
cthr-20230331_lab.xml Edgar Link unprocessable
cthr-20230331_pre.xml Edgar Link unprocessable
brhc20052247_10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending